A2A adenosine receptor regulates glia proliferation and pain after peripheral nerve injury

Pain

Volumn 140, Issue 1, 2008, Pages 95-103

  Bura, S Andreea ^a   Nadal, Xavier ^a   Ledent, Catherine ^b   Maldonado, Rafael ^a   Valverde, Olga ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

A2A adenosine receptor; A2A knockout mice; Analgesia; Astrocytes; Microglia; Neuropathic pain

Indexed keywords

ADENOSINE A2A RECEPTOR;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL PROLIFERATION; COLD PLATE TEST; CONTROLLED STUDY; EXPERIMENTAL TEST; FEMALE; GLIA CELL; HYPERALGESIA; KNOCKOUT MOUSE; MALE; MICROGLIA; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NERVE INJURY; PLANTAR TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCIATIC NERVE INJURY; SPINAL CORD; WILD TYPE;

ANIMALS; ASTROCYTES; CELL PROLIFERATION; HYPERALGESIA; MICE; MICE, KNOCKOUT; MICROGLIA; PAIN; RECEPTOR, ADENOSINE A2A; SCIATIC NEUROPATHY;

EID: 54249117648     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2008.07.012     Document Type: Article

References (51)

1. Bailey A., Ledent C., Kelly M., Hourani S.M., and Kitchen I. Changes in spinal delta and kappa opioid systems in mice deficient in the A2A receptor gene. J Neurosci 22 (2002) 9210-9220
2. Baños J.E., Sanchez G., Berrendero F., and Maldonado R. Neuropathic pain: some clues for future drug treatments. Mini Rev Med Chem 3 (2003) 719-727
3. Basbaum A.I. Spinal mechanisms of acute and persistent pain. Reg Anesth Pain Med 24 (1999) 59-67
4. Bastia E., Varani K., Monopoli A., and Bertorelli R. Effects of A(1) and A(2A) adenosine receptor ligands in mouse acute models of pain. Neurosci Lett 328 (2002) 241-244
5. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
6. Bours M.J., Swennen E.L., Di V.F., Cronstein B.N., and Dagnelie P.C. Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 112 (2006) 358-404
7. Brambilla R., Cottini L., Fumagalli M., Ceruti S., and Abbracchio M.P. Blockade of A2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes. Glia 43 (2003) 190-194
8. Bridges D., Thompson S.W., and Rice A.S. Mechanisms of neuropathic pain. Br J Anaesth 87 (2001) 12-26
9. Brooke R.E., Deuchars J., and Deuchars S.A. Input-specific modulation of neurotransmitter release in the lateral horn of the spinal cord via adenosine receptors. J Neurosci 24 (2004) 127-137
10. Castañe A., Celerier E., Martin M., Ledent C., Parmentier M., Maldonado R., et al. Development and expression of neuropathic pain in CB1 knockout mice. Neuropharmacology 50 (2006) 111-122
11. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53 (1994) 55-63
12. Choca J.I., Green R.D., and Proudfit H.K. Adenosine A1 and A2 receptors of the substantia gelatinosa are located predominantly on intrinsic neurons: an autoradiography study. J Pharmacol Exp Ther 247 (1988) 757-764
13. Clark A.K., Yip P.K., Grist J., Gentry C., Staniland A.A., Marchand F., et al. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc Natl Acad Sci USA 104 (2007) 10655-10660
14. Colburn R.W., Rickman A.J., and DeLeo J.A. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp Neurol 157 (1999) 289-304
15. Cunha G.M., Canas P.M., Oliveira C.R., and Cunha R.A. Increased density and synapto-protective effect of adenosine A2A receptors upon sub-chronic restraint stress. Neuroscience 141 (2006) 1775-1781
16. Cunha R.A. Neuroprotection by adenosine in the brain: from A(1) receptor activation to A (2A) receptor blockade. Purinergic Signal 1 (2005) 111-134
17. DeLeo J.A., and Yezierski R.P. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90 (2001) 1-6
18. Dunwiddie T.V., and Masino S.A. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24 (2001) 31-55
19. Ferre S., Diamond I., Goldberg S.R., Yao L., Hourani S.M., Huang Z.L., et al. Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain. Prog Neurobiol 83 (2007) 332-347
20. Fiebich B.L., Biber K., Lieb K., van C.D., Berger M., Bauer J., and Gebicke-Haerter P.J. Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors. Glia 18 (1996) 152-160
21. Fredholm B.B., IJzerman A.P., Jacobson K.A., Klotz K.N., and Linden J. International union of pharmacology XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53 (2001) 527-552
22. Ghelardini C., Galeotti N., and Bartolini A. Caffeine induces central cholinergic analgesia. Naunyn Schmiedebergs Arch Pharmacol 356 (1997) 590-595
23. Godfrey L., Yan L., Clarke G.D., Ledent C., Kitchen I., and Hourani S.M. Modulation of paracetamol antinociception by caffeine and by selective adenosine A2 receptor antagonists in mice. Eur J Pharmacol 531 (2006) 80-86
24. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
25. Hasko G., Pacher P., Vizi E.S., and Illes P. Adenosine receptor signaling in the brain immune system. Trends Pharmacol Sci 26 (2005) 511-516
26. Hindley S., Herman M.A., and Rathbone M.P. Stimulation of reactive astrogliosis in vivo by extracellular adenosine diphosphate or an adenosine A2 receptor agonist. J Neurosci Res 38 (1994) 399-406
27. Hussey M.J., Clarke G.D., Ledent C., Hourani S.M., and Kitchen I. Reduced response to the formalin test and lowered spinal NMDA glutamate receptor binding in adenosine A2A receptor knockout mice. Pain 129 (2007) 287-294
28. Kaelin-Lang A., Lauterburg T., and Burgunder J.M. Expression of adenosine A2a receptor gene in rat dorsal root and autonomic ganglia. Neurosci Lett 246 (1998) 21-24
29. Khasar S.G., Wang J.F., Taiwo Y.O., Heller P.H., Green P.G., and Levine J.D. Mu-opioid agonist enhancement of prostaglandin-induced hyperalgesia in the rat: a G-protein beta gamma subunit-mediated effect?. Neuroscience 67 (1995) 189-195
30. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19 (1996) 312-318
31. Laird J.M., and Bennett G.J. An electrophysiological study of dorsal horn neurons in the spinal cord of rats with an experimental peripheral neuropathy. J Neurophysiol 69 (1993) 2072-2085
32. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.F., Beslot F., et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283 (1999) 401-404
33. Ledent C., Vaugeois J.M., Schiffmann S.N., Pedrazzini T., El Yacoubi M., Vanderhaeghen J.J., et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388 (1997) 674-678
34. Li X.X., Nomura T., Aihara H., and Nishizaki T. Adenosine enhances glial glutamate efflux via A2a adenosine receptors. Life Sci 68 (2001) 1343-1350
35. Liou J.T., Liu F.C., Hsin S.T., Yang C.Y., and Lui P.W. Inhibition of the cyclic adenosine monophosphate pathway attenuates neuropathic pain and reduces phosphorylation of cyclic adenosine monophosphate response element-binding in the spinal cord after partial sciatic nerve ligation in rats. Anesth Analg 105 (2007) 1830-1837
36. Malmberg A.B., and Basbaum A.I. Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates. Pain 76 (1998) 215-222
37. Moreau J.L., and Huber G. Central adenosine A(2A) receptors: an overview. Brain Res Brain Res Rev 31 (1999) 65-82
38. Nishizaki T., Nagai K., Nomura T., Tada H., Kanno T., Tozaki H., et al. A new neuromodulatory pathway with a glial contribution mediated via A(2a) adenosine receptors. Glia 39 (2002) 133-147
39. Ribeiro J.A., Sebastiao A.M., and de M.A. Participation of adenosine receptors in neuroprotection. Drug News Perspect 16 (2003) 80-86
40. Sawynok J. Adenosine receptor activation and nociception. Eur J Pharmacol 347 (1998) 1-11
41. Sawynok J., and Liu X.J. Adenosine in the spinal cord and periphery: release and regulation of pain. Prog Neurobiol 69 (2003) 313-340
42. Sawynok J., Reid A., and Poon A. Peripheral antinociceptive effect of an adenosine kinase inhibitor, with augmentation by an adenosine deaminase inhibitor, in the rat formalin test. Pain 74 (1998) 75-81
43. Sawynok J., Reid A.R., and Doak G.J. Caffeine antinociception in the rat hot-plate and formalin tests and locomotor stimulation: involvement of noradrenergic mechanisms. Pain 61 (1995) 203-213
44. Takeda K., Sawamura S., Sekiyama H., Tamai H., and Hanaoka K. Effect of methylprednisolone on neuropathic pain and spinal glial activation in rats. Anesthesiology 100 (2004) 1249-1257
45. Tanga F.Y., Raghavendra V., and DeLeo J.A. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem Int 45 (2004) 397-407
46. Tawfik V.L., Regan M.R., Haenggeli C., Lacroix-Fralish M.L., Nutile-McMenemy N., Perez N., et al. Propentofylline-induced astrocyte modulation leads to alterations in glial glutamate promoter activation following spinal nerve transection. Neuroscience 152 (2008) 1086-1092
47. Tsuda M., Inoue K., and Salter M.W. Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci 28 (2005) 101-107
48. Watkins L.R., and Maier S.F. Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov 2 (2003) 973-985
49. Watkins L.R., Milligan E.D., and Maier S.F. Glial activation: a driving force for pathological pain. Trends Neurosci 24 (2001) 450-455
50. Yoon M.H., Bae H.B., and Choi J.I. Antinociception of intrathecal adenosine receptor subtype agonists in rat formalin test. Anesth Analg 101 (2005) 1417-1421
51. Zhang J., Shi X.Q., Echeverry S., Mogil J.S., De K.Y., and Rivest S. Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J Neurosci 27 (2007) 12396-12406